TEVA-TERIFLUNOMIDE

Identification of Teva-Teriflunomide

No description

Google image searchProduct monograph

Active ingredient

teriflunomide, 14 MG

DIN: 02501090

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 16-MAY-2022

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AK — Dihydroorotate dehydrogenase (DHODH) inhibitors (ATC, ATC/DDD)
• L04AK02 — TERIFLUNOMIDE (ATC/DDD)

Reference brand drug: Aubagio

External Links for Teva-Teriflunomide

Search on Google

• Teva-Teriflunomide side effects
• Teva-Teriflunomide dosage
• teriflunomide side effects
• teriflunomide dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-teriflunomide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.